Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: Influences on bone and mineral metabolism

Bone

Volumn 39, Issue 6, 2006, Pages 1352-1360

  Baek, Ki Hyun ^a   Oh, Ki Won ^b   Lee, Won Young ^b   Tae, Hyun Jung ^a   Rhee, Eun Jung ^b   Han, Je Ho ^a   Cha, Bong Yun ^a   Kim, Yoo Jin ^a,c   Lee, Kwang Woo ^a   Son, Ho Young ^a   Kang, Sung Koo ^a   Kim, Chun Choo ^a,c   Kang, Moo Il ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Bone marrow transplantation; Bone mineral density; Bone turnover marker; IL 7; Osteoprotegerin; RANKL; Sex steroids

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; ESTRADIOL; INTERLEUKIN 7; MINERAL; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SEX HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BONE DENSITY; BONE MARROW TRANSPLANTATION; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CORRELATION ANALYSIS; DATA ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; MALE; MINERAL METABOLISM; OSSIFICATION; OSTEOLYSIS; POSTOPERATIVE PERIOD; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; UPREGULATION;

ADULT; BONE AND BONES; BONE DENSITY; BONE MARROW TRANSPLANTATION; BONE REMODELING; BONE RESORPTION; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; INTERLEUKIN-7; LUTEINIZING HORMONE; MALE; OSTEOPROTEGERIN; RANK LIGAND; SOLUBILITY; TESTOSTERONE;

EID: 35348832763     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.06.011     Document Type: Article

References (23)

1. Kang M.I., Lee W.Y., Oh K.W., Han J.H., Song K.H., Cha B.Y., et al. The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 26 (2000) 275-279
2. Ebeling P.R., Thomas D.M., Erbas B., Hopper J.L., Szer J., and Grigg A.P. Mechanisms of bone loss following allogeneic and autologous hematopoietic stem cell transplantation. J. Bone Miner. Res. 14 (1999) 342-350
3. Välimäki M.J., Kinnunen K., Volin L., Tähtelä R., Löyttyniemi E., Laitinen K., et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant. 23 (1999) 355-361
4. Schulte C., Beelen D.W., Schaefer U.W., and Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos. Int. 11 (2000) 344-353
5. Baek K.H., Lee W.Y., Oh K.W., Kim H.S., Han J.H., Kang M.I., et al. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J. Clin. Endocrinol. Metab. 89 (2004) 1246-1254
6. Stern J.M., Sullivan K.M., Ott S.M., Seidel K., Fink J.C., Longton G., et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol. Blood Marrow Transplant. 7 (2001) 257-264
7. Buchs N., Helg C., Collao C., Chapuis B., Slosman D., Bonjour J.P., et al. Allogenic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos. Int. 12 (2001) 880-886
8. Kashyap A., Kandeel F., Yamauchi D., Palmer J.M., Niland J.C., Molina A., et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: a prospective study. Biol. Blood Marrow Transplant. 6 (2000) 344-351
9. Lee W.Y., Kang M.I., Oh E.S., Oh K.W., Han J.H., Cha B.Y., et al. The role of cytokines in the changes of bone turnover following bone marrow transplantation. Osteoporos. Int. 13 (2002) 62-68
10. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
11. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
12. Hofmeister R., Khaled A.R., Benbernou N., Rajnavolgyi E., Muegge K., and Durum S.K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10 (1999) 41-60
13. Toraldo G., Roggia C., Qian W.P., Pacifici R., and Weitzmann M.N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 125-130
14. Weitzmann M.N., Cenci S., Rifas L., Brown C., and Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 96 (2000) 1873-1878
15. Weitzmann M.N., Roggia C., Toraldo G., Weitzmann L., and Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 110 (2002) 1643-1650
16. Lee W.Y., Baek K.H., Rhee E.J., Tae H.J., Oh K.W., Kang M.I., et al. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant. 34 (2004) 89-94
17. Withold W., Wolf H.H., Kollbach S., Heyll A., Schneider W., and Reinauer H. Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation. Eur. J. Clin. Chem. Clin. Biochem. 34 (1996) 295-299
18. Hofbauer L.C., Gori F., Riggs B.L., Lacey D.L., Dunstan C.R., Spelsberg T.C., et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140 (1999) 4382-4389
19. Kwan Tat S., Padrines M., Theoleyre S., Heymann D., and Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15 (2004) 49-60
20. Garcia Palacios V., Robinson L.J., Borysenko C.W., Lehmann T., Kalla S.E., and Blair H.C. Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J. Biol. Chem. 280 (2005) 13720-13727
21. Syed F., and Khosla S. Mechanisms of sex steroid effects on bone. Biochem. Biophys. Res. Commun. 328 (2005) 688-696
22. Falahati-Nini A., Riggs B.L., Atkinson E.J., O'Fallon W.M., Eastell R., and Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J. Clin. Invest. 106 (2000) 1553-1560
23. Miyaura C., Onoe Y., Inada M., Maki K., Ikuta K., Ito M., et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9360-9365